pH- and Thiol-Responsive BODIPY-Based Photosensitizers for Targeted Photodynamic Therapy.

A diiodo distyryl boron dipyrromethene (BODIPY) core was conjugated to two ferrocenyl quenchers through acid-labile ketal and/or thiol-cleavable disulfide linkers, of which the fluorescence and photosensitizing properties were significantly quenched through a photoinduced electron-transfer process. The two symmetrical analogues that contained either the ketal or disulfide linkers could only be activated by a single stimulus, whereas the unsymmetrical analogue was responsive to dual stimuli. Upon interaction with acid and/or dithiothreitol (DTT), these linkers were cleaved selectively. The separation of the BODIPY core and the ferrocenyl moieties restored the photoactivities of the former in phosphate buffered saline and inside the MCF-7 breast cancer cells, rendering these compounds as potential activable photosensitizers for targeted photodynamic therapy. The dual activable analogue exhibited the greatest enhancement in intracellular fluorescence intensity in both an acidic environment (pH 5) and the presence of DTT (4 mm). Its photocytotoxicity against MCF-7 cells also increased by about twofold upon preincubation with 4 mm of DTT. The activation of this compound was also demonstrated in nude mice bearing a HT29 human colorectal carcinoma. A significant increase in fluorescence intensity in the tumor was observed over 9 h after intratumoral injection.

[1]  Fang Zeng,et al.  Dual-targeting nanosystem for enhancing photodynamic therapy efficiency. , 2015, ACS applied materials & interfaces.

[2]  Yongdoo Choi,et al.  Photosensitizer-Conjugated Gold Nanorods for Enzyme-Activatable Fluorescence Imaging and Photodynamic Therapy , 2012, Theranostics.

[3]  R. Weissleder,et al.  Protease‐Mediated Phototoxicity of a Polylysine–Chlorine6 Conjugate , 2006, ChemMedChem.

[4]  Yongdoo Choi,et al.  Gold nanorod-photosensitizer complex for near-infrared fluorescence imaging and photodynamic/photothermal therapy in vivo. , 2011, ACS nano.

[5]  L. Juillerat-Jeanneret,et al.  Drug targeting strategies for photodynamic therapy. , 2012, Anti-cancer agents in medicinal chemistry.

[6]  K. Huh,et al.  Self-quenchable biofunctional nanoparticles of heparin–folate-photosensitizer conjugates for photodynamic therapy , 2011 .

[7]  Ronghua Yang,et al.  Regulation of singlet oxygen generation using single-walled carbon nanotubes. , 2008, Journal of the American Chemical Society.

[8]  E. Ferapontova,et al.  An RNA aptamer-based electrochemical biosensor for detection of theophylline in serum. , 2008, Journal of the American Chemical Society.

[9]  R. Jain,et al.  Photodynamic therapy for cancer , 2003, Nature Reviews Cancer.

[10]  Kwangmeyung Kim,et al.  Cancer cell-specific photoactivity of pheophorbide a-glycol chitosan nanoparticles for photodynamic therapy in tumor-bearing mice. , 2013, Biomaterials.

[11]  Jianzhang Zhao,et al.  Activatable triplet photosensitizers: magic bullets for targeted photodynamic therapy , 2014 .

[12]  V. Rotello,et al.  Glutathione-mediated delivery and release using monolayer protected nanoparticle carriers. , 2006, Journal of the American Chemical Society.

[13]  M. Barberi-Heyob,et al.  Modulation of photosensitization processes for an improved targeted photodynamic therapy. , 2010, Current medicinal chemistry.

[14]  Stanley B. Brown,et al.  The present and future role of photodynamic therapy in cancer treatment. , 2004, The Lancet. Oncology.

[15]  G. R. Bright,et al.  Reduction of Intracellular pH Is Not the Mechanism for the Synergistic Interaction Between Photodynamic Therapy and Nigericin , 1996, Photochemistry and photobiology.

[16]  Hyunjin Kim,et al.  A graphene oxide-photosensitizer complex as an enzyme-activatable theranostic agent. , 2013, Chemical communications.

[17]  Ick Chan Kwon,et al.  Nanophotosensitizers toward advanced photodynamic therapy of Cancer. , 2013, Cancer letters.

[18]  Youngmi Kim,et al.  ROS-Responsive Activatable Photosensitizing Agent for Imaging and Photodynamic Therapy of Activated Macrophages , 2013, Theranostics.

[19]  Pui-Chi Lo,et al.  A glutathione-activated phthalocyanine-based photosensitizer for photodynamic therapy. , 2014, Chemistry.

[20]  Shouwu Guo,et al.  Folic Acid-conjugated Graphene Oxide loaded with Photosensitizers for Targeting Photodynamic Therapy , 2011, Theranostics.

[21]  Ick Chan Kwon,et al.  Tumor-homing photosensitizer-conjugated glycol chitosan nanoparticles for synchronous photodynamic imaging and therapy based on cellular on/off system. , 2011, Biomaterials.

[22]  E. Akkaya,et al.  Thinking outside the silicon box: molecular and logic as an additional layer of selectivity in singlet oxygen generation for photodynamic therapy. , 2009, Journal of the American Chemical Society.

[23]  Gang Zheng,et al.  Activatable photosensitizers for imaging and therapy. , 2010, Chemical reviews.

[24]  D. Ng,et al.  A dual activatable photosensitizer toward targeted photodynamic therapy. , 2014, Journal of medicinal chemistry.

[25]  K. Na,et al.  Self-quenching polysaccharide-based nanogels of pullulan/folate-photosensitizer conjugates for photodynamic therapy. , 2010, Biomaterials.

[26]  Saehun Mun,et al.  Photosensitizer-conjugated polymeric nanoparticles for redox-responsive fluorescence imaging and photodynamic therapy. , 2013, Journal of materials chemistry. B.

[27]  B. Wilson,et al.  FRET quenching of photosensitizer singlet oxygen generation. , 2009, The journal of physical chemistry. B.

[28]  Ulysses W. Sallum,et al.  Exploiting a bacterial drug-resistance mechanism: a light-activated construct for the destruction of MRSA. , 2009, Angewandte Chemie.

[29]  Yongdoo Choi,et al.  Graphene oxide-photosensitizer conjugate as a redox-responsive theranostic agent. , 2012, Chemical communications.

[30]  R. Cetin-Atalay,et al.  Near-IR absorbing BODIPY derivatives as glutathione-activated photosensitizers for selective photodynamic action. , 2014, Chemistry.

[31]  Hui He,et al.  Preparation of unsymmetrical distyryl BODIPY derivatives and effects of the styryl substituents on their in vitro photodynamic properties. , 2011, Chemical communications.

[32]  Peng Liu,et al.  Photosensitizer-conjugated redox-responsive dextran theranostic nanoparticles for near-infrared cancer imaging and photodynamic therapy , 2014 .

[33]  R. Weissleder,et al.  Selective antitumor effect of novel protease-mediated photodynamic agent. , 2006, Cancer research.

[34]  D. Ng,et al.  A disulfide-linked conjugate of ferrocenyl chalcone and silicon(IV) phthalocyanine as an activatable photosensitiser. , 2013, Chemical communications.

[35]  Jin-Yong Park,et al.  Photodynamic Therapy Using a Protease-Mediated Theranostic Agent Reduces Cathepsin-B Activity in Mouse Atheromata In Vivo , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[36]  Huangxian Ju,et al.  Folate receptor-targeted and cathepsin B-activatable nanoprobe for in situ therapeutic monitoring of photosensitive cell death. , 2015, Analytical chemistry.

[37]  D. F. Eaton,et al.  International Union of Pure and Applied Chemistry Organic Chemistry Division Commission on Photochemistry. Reference materials for fluorescence measurement. , 1988, Journal of photochemistry and photobiology. B, Biology.

[38]  Mei-Rong Ke,et al.  A pH-responsive fluorescent probe and photosensitiser based on a self-quenched phthalocyanine dimer. , 2012, Chemical communications.

[39]  J. Lindsey,et al.  Masked imidazolyl-dipyrromethanes in the synthesis of imidazole-substituted porphyrins. , 2006, The Journal of organic chemistry.

[40]  G. Zheng,et al.  Peptide-based molecular beacons for cancer imaging and therapy , 2011, Amino Acids.

[41]  C. Marquis,et al.  Acid Degradable and Biocompatible Polymeric Nanoparticles for the Potential Codelivery of Therapeutic Agents , 2011 .

[42]  E. Durantini,et al.  Synthesis, properties, and photodynamic inactivation of Escherichia coli using a cationic and a noncharged Zn(II) pyridyloxyphthalocyanine derivatives. , 2005, Bioorganic & medicinal chemistry.

[43]  M. Koyama,et al.  An improved colorimetric assay for interleukin 2. , 1986, Journal of immunological methods.

[44]  A. Bugaj.  Targeted photodynamic therapy — a promising strategy of tumor treatment , 2011, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[45]  K. Burgess,et al.  BODIPY dyes in photodynamic therapy. , 2013, Chemical Society reviews.